RhumbLine Advisers’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-109,706
Closed -$8.76M 3192
2021
Q1
$8.76M Sell
109,706
-3,197
-3% -$255K 0.01% 1075
2020
Q4
$8.9M Buy
112,903
+3,851
+4% +$304K 0.01% 1000
2020
Q3
$4.79M Sell
109,052
-12,046
-10% -$529K 0.01% 1198
2020
Q2
$5.36M Buy
121,098
+15,911
+15% +$704K 0.01% 1172
2020
Q1
$3.78M Buy
105,187
+3,560
+4% +$128K 0.01% 1199
2019
Q4
$7.21M Buy
101,627
+1,634
+2% +$116K 0.01% 1040
2019
Q3
$7.48M Sell
99,993
-712
-0.7% -$53.3K 0.01% 947
2019
Q2
$8.12M Sell
100,705
-2,033
-2% -$164K 0.02% 904
2019
Q1
$6.87M Buy
102,738
+1,126
+1% +$75.3K 0.01% 987
2018
Q4
$7.57M Buy
101,612
+21,175
+26% +$1.58M 0.02% 860
2018
Q3
$7.41M Sell
80,437
-595
-0.7% -$54.8K 0.01% 856
2018
Q2
$7.97M Buy
81,032
+5,724
+8% +$563K 0.02% 794
2018
Q1
$8.39M Sell
75,308
-12,540
-14% -$1.4M 0.02% 742
2017
Q4
$9.04M Buy
87,848
+11,352
+15% +$1.17M 0.02% 729
2017
Q3
$7.2M Buy
76,496
+870
+1% +$81.9K 0.02% 833
2017
Q2
$5.89M Sell
75,626
-497
-0.7% -$38.7K 0.01% 908
2017
Q1
$6.1M Buy
76,123
+5,949
+8% +$476K 0.01% 888
2016
Q4
$5.53M Buy
70,174
+3,204
+5% +$252K 0.01% 883
2016
Q3
$5.22M Buy
66,970
+3,491
+5% +$272K 0.01% 857
2016
Q2
$4.36M Buy
63,479
+1,561
+3% +$107K 0.01% 885
2016
Q1
$4.42M Buy
61,918
+1,030
+2% +$73.5K 0.01% 901
2015
Q4
$3.78M Buy
60,888
+4,080
+7% +$254K 0.01% 958
2015
Q3
$3.22M Sell
56,808
-3,144
-5% -$178K 0.01% 1050
2015
Q2
$3.22M Sell
59,952
-2,675
-4% -$144K 0.01% 1103
2015
Q1
$2.98M Buy
62,627
+23,967
+62% +$1.14M 0.01% 1134
2014
Q4
$1.67M Sell
38,660
-525
-1% -$22.7K ﹤0.01% 1480
2014
Q3
$1.35M Buy
39,185
+715
+2% +$24.6K ﹤0.01% 1568
2014
Q2
$1.41M Sell
38,470
-1,226
-3% -$44.9K ﹤0.01% 1604
2014
Q1
$1.34M Sell
39,696
-1,527
-4% -$51.5K ﹤0.01% 1612
2013
Q4
$1.4M Sell
41,223
-280
-0.7% -$9.5K ﹤0.01% 1586
2013
Q3
$1.32M Sell
41,503
-1,856
-4% -$59.1K ﹤0.01% 1597
2013
Q2
$979K Buy
+43,359
New +$979K ﹤0.01% 1783